New treatments for deadly snake bites, and a fusion company that wants to get in the medical isotopes game

Science Magazine Podcast

Science Podcast

News Commentary, News, Science

4.2 • 791 Ratings

🗓️ 18 July 2024

⏱️ 32 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

First up this week, Staff Writer Adrian Cho talks with host Sarah Crespi about a fusion company that isn’t aiming for net energy. Instead, it’s looking to sell off the high-energy neutrons from its fusion reactors for different purposes, such as imaging machine parts and generating medical isotopes. In the long run, the company hopes to use money from these neutron-based enterprises for bigger, more energetic reactors that may someday make fusion energy. Next, we hear from Tian Du, a Ph.D. candidate in the Dr John and Anne Chong Lab for Functional Genomics at the University of Sydney. She talks about finding antivenom treatments by screening all the genes in the human genome. Her Science Translational Medicine paper focuses on a strong candidate for treating spitting cobra bites, but the technique may prove useful for many other venomous animal bites and stings, from jellyfish to spiders. This week’s episode was produced with help from Podigy. About the Science Podcast Authors: Sarah Crespi, Adrian Cho Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Morgan State University, a Baltimore, Maryland Carnegie R2 doctoral research institution,
0:05.0	offers more than 100 academic programs and awards degrees at the Bacclureate, Masters, and Doctoral
0:11.4	Levels, is furthering their mission of growing the future leading the world.
0:16.0	Morgan continues to address the needs and challenges of the modern urban environment.
0:20.0	With a four-year quadrupling
0:22.3	of research, more than a dozen new doctoral programs, and eight new National Centers of Excellence,
0:28.4	Morgan is positioned to achieve Carnegie R1 designation in the next five years. To learn more about
0:34.5	Morgan and their ascension to R1, visit morgan.edu slash research.
0:40.4	This podcast is supported by the Icon School of Medicine at Mount Sinai, one of America's leading research medical schools.
0:48.0	Icon Mount Sinai is the academic arm of the eight hospital Mount Sinai health system in New York City.
0:55.9	It's consistently among the top recipients of NIH funding. Researchers at ICONMount Sinai have made breakthrough discoveries in many
1:02.1	fields vital to advancing the health of patients, including cancer, COVID and long COVID,
1:08.7	cardiology, neuroscience, and artificial intelligence.
1:12.5	The Icon School of Medicine at Mount Sinai, we find a way.
1:22.2	This is a science podcast for July 19th, 2024. I'm Sarah Crespi. First up this week, staff writer Adrian Cho
1:30.2	talks about a fusion company that isn't aiming to sell energy, at least in the short term. Instead,
1:35.8	they're looking to market the high energy neutrons from its fusion reactors for x-ray imaging
1:39.9	and medical isotopes, with the hope that one day with the money from those businesses,
1:44.5	they could upgrade to selling energy.
1:47.3	Next, I speak with researcher Tien-Doo about finding snake anti-venom treatments by screening
1:52.4	all the genes in the human genome.
1:54.7	Her paper focuses on a strong candidate for treating spitting cobra bites, but the technique
	...

Transcript will be available on the free plan in -255 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Science Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Science Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.